imagabalin: Clinical Trials

6 trials of imagabalin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 1 completed, 1 withdrawn. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 4, Completed 1, Withdrawn 1

Follow imagabalin: new trials by email Literature Review of imagabalin trials Research Report on imagabalin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
PD-0332334 - Generalized Anxiety Disorder
Phase 3WithdrawnPfizer2009-01-012012-12-03
A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
PD 0332334 - Generalized Anxiety Disorder
Phase 3TerminatedPfizer4682008-10-012012-11-16
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
PD 0332334, Paroxetine, Placebo - Generalized Anxiety Disorder
Phase 3TerminatedPfizer3602008-05-012012-11-16
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
PD 0332334, paroxetine, Placebo - Generalized Anxiety Disorder
Phase 3TerminatedPfizer2862008-05-012012-11-16
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
PD 0332334, Paroxetine, Placebo - Generalized Anxiety Disorder
Phase 3TerminatedPfizer5012008-04-012012-11-16
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
PD 0332334, Placebo - Generalized Anxiety Disorder
Phase 3CompletedPfizer5512007-10-012012-11-16

Conditions studied

Generalized Anxiety Disorder (6)

Sponsors

Pfizer (6)

Countries

United States (6)  ·  Hungary (3)  ·  Russia (2)  ·  Italy (1)  ·  South Korea (1)  ·  Taiwan (1)